We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Official: Agency Shouldn’t Be Conduit for Trial Transparency
FDA Official: Agency Shouldn’t Be Conduit for Trial Transparency
July 31, 2013
While various stakeholders are urging more clinical trial data sharing, the FDA does not believe it should be the agency tasked with aggregating and making such data widely available, an FDA official says.